GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a prominent focus in therapeutic studies, largely due to its remarkable impact on managing diseases such as type 2 diabetes and obesity. New studies have demonstrated that beyond glucose regulation, GLP-1 drugs offer potential for cardiovascular well-being and even